XML 53 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2013
Share-based Compensation [Abstract]  
Fair Value of Option Grants Used in Measuring Compensation Expense
The fair value of stock option grants used in measuring compensation expense was determined using the Black-Scholes option pricing model with the following weighted-average assumptions.
 
 
2013
 
2012
 
2011
Risk-free interest rate
 
1.11
%
 
1.23
%
 
NA
Expected stock price volatility
 
50.0

 
65.0

 
NA
Dividend yield
 
1.6

 
2.0

 
NA
Expected life of options
 
6.0 years

 
6.0 years

 
NA
 
 
 
 
 
 
 
Schedule of Stock Options Activity
A summary of stock option activity and changes during the years ended December 31, 2013, 2012, and 2011 is presented below.
Stock Options
 
 
 
 
 
 
2013
 
2012
 
2011
 
Shares
 
Weighted-Average Exercise Price
 
Shares
 
Weighted-Average Exercise Price
 
Shares
 
Weighted-Average Exercise Price
Outstanding at beginning of year
19,289,705

 
$
8.40

 
17,886,318

 
$
10.63

 
21,723,381

 
$
10.81

Options granted
6,003,250

 
2.52

 
4,586,666

 
2.05

 
—

 
—

Options exercised
(455,767
)
 
2.47

 
—

 
—

 
—

 
—

Options forfeited
(364,075
)
 
2.35

 
(174,842
)
 
2.38

 
(471,386
)
 
10.72

Options expired
(1,932,345
)
 
8.98

 
(3,008,437
)
 
12.36

 
(3,365,677
)
 
11.75

Options outstanding at end of year
22,540,768

 
$
7.00

 
19,289,705

 
$
8.40

 
17,886,318

 
$
10.63

Options exercisable at end of year
13,994,362

 
$
9.82

 
13,296,595

 
$
10.94

 
14,365,773

 
$
12.06

 
 
 
 
 
 
 
 
 
 
 
 
Schedule of Nonvested Share Activity
December 31, 2013 with a grant date fair value of $3.49. The number of market restricted share units that will ultimately vest ranges from 75% to 125% of target based on Synovus' total shareholder return. At December 31, 2013, total unrecognized compensation cost related to market restricted share units was approximately $990 thousand with a weighted average remaining period of 1.50 years.
Schedule of Restricted Stock Units Activity
A summary of restricted share units outstanding and changes during the years ended December 31, 2013, 2012, and 2011 is presented below (excluding market restricted share units described above).
Restricted Share Units
Share Units
 
Weighted-Average Grant-date Fair Value
Outstanding at January 1, 2011
880,401

 
$
3.05

Granted
3,815,942

 
2.65

Dividend equivalents granted
86,494

 
1.64

Vested
(25,534
)
 
6.15

Forfeited
(229,328
)
 
2.91

Outstanding at December 31, 2011
4,527,975

 
2.67

Granted
3,330,293

 
2.07

Dividend equivalents granted
112,616

 
2.19

Vested
(1,314,063
)
 
2.70

Forfeited
(213,842
)
 
2.49

Outstanding at December 31, 2012
6,442,979

 
2.35

Granted    
1,488,620

 
2.80

Dividend equivalents granted    
74,820

 
3.00

Vested
(3,816,081
)
 
2.56

Forfeited    
(118,599
)
 
2.07

Outstanding at December 31, 2013
4,071,739

 
$
2.34

 
 
 
 
Schedule of Grants Under All Synovus Equity Compensation Plans
The following table provides aggregate information regarding grants under all Synovus equity compensation plans through December 31, 2013.

 
 
 
 
Plan Category(1)    
 
(a) Number of securities to be issued upon vesting of restricted share units
 
(b) Number of securities to be issued upon exercise of outstanding options
 
(c) Weighted-average exercise price of outstanding options in column (b)
 
(d) Number of shares remaining available for issuance excluding shares reflected in columns (a) and (b)
 
Shareholder approved equity compensation plans for shares of Synovus stock
 
4,071,739

 
22,437,168

 
$
6.96

 
57,126,291

(2) 
Non-shareholder approved equity compensation plans
 
—

 
—

 
—

 
—

 
Total
 
4,071,739

 
22,437,168

 
$
6.96

 
57,126,291

 
 
 
 
 
 
 
 
 
 
 
(1) Does not include information for equity compensation plans assumed by Synovus in mergers. A total of 103,600 shares of Common Stock were issuable upon exercise of options granted under plans assumed in mergers and outstanding at December 31, 2013. The weighted average exercise price of all options granted under plans assumed in mergers and outstanding at December 31, 2013 was $8.53. Synovus cannot grant additional awards under these assumed plans.
(2) Includes 57,126,291 shares available for future grants as share awards under the 2013 Omnibus Plan.